Maiello MR - Search Results

1

The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.

Normanno N, De Luca A, Maiello MR, Campiglio M, Napolitano M, Mancino M, Carotenuto A, Viglietto G, Menard S. Normanno N, et al. Among authors: maiello mr. J Cell Physiol. 2006 May;207(2):420-7. doi: 10.1002/jcp.20588. J Cell Physiol. 2006. PMID: 16419029

2

Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.

Bianco C, Normanno N, De Luca A, Maiello MR, Wechselberger C, Sun Y, Khan N, Adkins H, Sanicola M, Vonderhaar B, Cohen B, Seno M, Salomon D. Bianco C, et al. Among authors: maiello mr. J Cell Physiol. 2002 Jan;190(1):74-82. doi: 10.1002/jcp.10037. J Cell Physiol. 2002. PMID: 11807813

3

Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth.

Normanno N, Campiglio M, De LA, Somenzi G, Maiello M, Ciardiello F, Gianni L, Salomon DS, Menard S. Normanno N, et al. Ann Oncol. 2002 Jan;13(1):65-72. doi: 10.1093/annonc/mdf020. Ann Oncol. 2002. PMID: 11863114 Free article.

4

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?

Normanno N, Maiello MR, De Luca A. Normanno N, et al. Among authors: maiello mr. J Cell Physiol. 2003 Jan;194(1):13-9. doi: 10.1002/jcp.10194. J Cell Physiol. 2003. PMID: 12447985 Review.

5

Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.

Normanno N, Bianco C, De Luca A, Maiello MR, Salomon DS. Normanno N, et al. Among authors: maiello mr. Endocr Relat Cancer. 2003 Mar;10(1):1-21. doi: 10.1677/erc.0.0100001. Endocr Relat Cancer. 2003. PMID: 12653668 Review.

6

Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.

Normanno N, De Luca A, Bianco C, Maiello MR, Carriero MV, Rehman A, Wechselberger C, Arra C, Strizzi L, Sanicola M, Salomon DS. Normanno N, et al. Among authors: maiello mr. J Cell Physiol. 2004 Jan;198(1):31-9. doi: 10.1002/jcp.10375. J Cell Physiol. 2004. PMID: 14584041

7

CRIPTO-1: a novel target for therapeutic intervention in human carcinoma.

Normanno N, De Luca A, Maiello MR, Bianco C, Mancino M, Strizzi L, Arra C, Ciardiello F, Agrawal S, Salomon DS. Normanno N, et al. Among authors: maiello mr. Int J Oncol. 2004 Oct;25(4):1013-20. Int J Oncol. 2004. PMID: 15375551

8

Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?

De Luca A, Grassii M, Maiello MR, Di Maio M, Mancino M, De Maio E, Gridelli C, Perrone F, Normanno N. De Luca A, et al. Among authors: maiello mr. Anticancer Res. 2004 Sep-Oct;24(5A):2985-9. Anticancer Res. 2004. PMID: 15517905 Free article.

9

Small molecule epidermal growth factor receptor tyrosine kinase inhibitors: an overview.

Normanno N, Maiello MR, Mancino M, De Luca A. Normanno N, et al. Among authors: maiello mr. J Chemother. 2004 Nov;16 Suppl 4:36-40. doi: 10.1179/joc.2004.16.Supplement-1.36. J Chemother. 2004. PMID: 15688607 Review.

10

The ErbB receptors and their ligands in cancer: an overview.

Normanno N, Bianco C, Strizzi L, Mancino M, Maiello MR, De Luca A, Caponigro F, Salomon DS. Normanno N, et al. Among authors: maiello mr. Curr Drug Targets. 2005 May;6(3):243-57. doi: 10.2174/1389450053765879. Curr Drug Targets. 2005. PMID: 15857286 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters